NIVOLUMAB PLUS BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA: EXTENDED FOLLOW‐UP FROM THE PHASE 2 CHECKMATE 436 STUDY

Saved in:
Bibliographic Details
Published in:Hematological oncology 2021-06, Vol.39 (S2)
Main Authors: Zinzani, P. L., Santoro, A., Gritti, G., Brice, P., Barr, P. M., Kuruvilla, J., Cunningham, D., Kline, J., Johnson, N. A., Mehta‐Shah, N., Fanale, M., Francis, S., Moskowitz, A. J.
Format: Article
Language:English
Subjects:
B-cell lymphoma
Immunotherapy
Lymphoma
Monoclonal antibodies
Targeted cancer therapy
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.51_2879